Topic:

Discovery IT

Latest Headlines

Latest Headlines

Apple, IBM team up for Watson-fueled assault on health research

Apple just gained a powerful ally in its push to make ResearchKit a core component of the health research toolkit. The Silicon Valley tech giant has tapped IBM for access to Watson, the data-mining and predictive analytics capabilities of which will be applied to health research.

Amgen's deCODE lays marker for future of genomics-driven drug discovery

Amgen's deCODE Genetics has released a glimpse of a future in which population-scale genome sequencing forms the basis of drug discovery programs. And while the initiative still has some technical shortcomings and has yet to prove to the outside world it is worth $415 million, it nonetheless sparked excitement in the genomics community.

Biogen taps Google's data analytics skills for MS research

The Google X lab that spawned smart contact lenses and self-driving cars is teaming up with Biogen Idec to unravel patient-to-patient variation in the progression of multiple sclerosis.

Transcriptic offers Y Combinator biotechs $20,000 credit for its robotic labs

The 10 biotechs in the latest batch of Y Combinator startups--as well as those that have already graduated from the incubator--will receive $20,000 to spend at Transcriptic's automated life science laboratory.

Nvidia backs projects to tap GPUs for cancer research

The Nvidia Foundation has awarded $400,000 to computational cancer projects at the Dana-Farber Cancer Institute and Stanford University. Nvidia backed the two projects--which took an equal split of the funding--as part of an initiative to finance programs that use parallel computing to advance cancer research.

AMP creates informatics subdivision

Bioinformatics has taken another step toward cementing itself in the life sciences mainstream. The latest validation of the importance of informatics comes from the Association for Molecular Pathology, which has established a subdivision focused on the field.

EMA to discuss possible glitch in Thermo bioequivalence software

Increased reliance on software to support aspects of drug development has simplified many tasks but created the possibility that an IT glitch could have far-reaching implications. Now, the European Medicines Agency is to discuss whether this situation has already happened.

NIH backs database-driven approach to neuromuscular research

The National Institutes of Health (NIH) has awarded a clutch of big-name academic centers funding to create a database for studying motor neuron disorders. By embarking on a large-scale data generation drive and analyzing the resulting information, the collaborators hope to build profiles for Lou Gehrig's disease and other neuromuscular conditions.

Takeda strikes deal with C4X to access 3D drug structure tech

Takeda Pharmaceutical's United Kingdom subsidiary has begun working with C4X Discovery to improve its lead discovery and hit identification. The agreement is centered on C4XD's 3D drug technology, a nuclear magnetic resonance-based method of viewing the structure of a molecule.

J&J, Sanofi apply IBM's Watson to R&D

IBM has opened up its Watson supercomputer to drug researchers through a new cloud-based service. And Big Pharma companies are already on board, with Johnson & Johnson and Sanofi among the early adopters of the technology.